View More View Less
  • 1 Shiraz University of Medical Sciences Department of Pharmacology Shiraz 71348-53185 Iran
  • | 2 Shiraz University of Medical Sciences Medicinal and Natural Products Chemistry Research Center Shiraz Iran
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $752.00

  • Abede W, Harris KH, MacLeod KM: Enhanced contractile responses of arteries from diabetic rats to alpha 1-adrenoceptor stimulation in the absence and presence of extracellular calcium. J. Cardiovasc. Pharmacol. 16, 239–248 (1990)

    MacLeod K.M. , 'Enhanced contractile responses of arteries from diabetic rats to alpha 1-adrenoceptor stimulation in the absence and presence of extracellular calcium ' (1990 ) 16 J. Cardiovasc. Pharmacol. : 239 -248.

    • Search Google Scholar
  • Allely MC, Brown CM, Kenny BA, Kilpatrick AT, Martin A, Spedding M: Modulation of alpha 1-adrenoceptors in rat left ventricle by ischaemia and acyl carnitines: protection by ranolazine. J. Cardiovasc. Pharmacol. 21, 869–873 (1993)

    Spedding M. , 'Modulation of alpha 1-adrenoceptors in rat left ventricle by ischaemia and acyl carnitines: protection by ranolazine ' (1993 ) 21 J. Cardiovasc. Pharmacol. : 869 -873.

    • Search Google Scholar
  • Antzelevitch C, Belardinelli L, Zygmunt AC, Burashnikov A, Di Diego JM, Fish JM, Cordeiro JM, Thomas G: Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties. Circulation 110, 904–910 (2004)

    Thomas G. , 'Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties ' (2004 ) 110 Circulation : 904 -910.

    • Search Google Scholar
  • Belardinelli L, Shryock JC, Fraser H: The mechanism of ranolazine action to reduce ischemia-induced diastolic dysfunction. Eur. Heart J. Suppl. 8, A10–A13 (2006)

    Fraser H. , 'The mechanism of ranolazine action to reduce ischemia-induced diastolic dysfunction ' (2006 ) 8 Eur. Heart J. Suppl. : A10 -A13.

    • Search Google Scholar
  • Castillo C, Ceballos G, Rodríguez D, Villanueva D, Medina R, López J, Mendez E, Castillo EF: Effects of estradiol on phenylephrine contractility associated with intracellular calcium release in rat aorta. Am. J. Physiol. Cell. Physiol. 291, C1388–C1394 (2006)

    Castillo E.F. , 'Effects of estradiol on phenylephrine contractility associated with intracellular calcium release in rat aorta ' (2006 ) 291 Am. J. Physiol. Cell. Physiol. : C1388 -C1394.

    • Search Google Scholar
  • Chaitman BR: Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions. Circulation 113, 2462–2472 (2006)

    Chaitman B.R. , 'Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions ' (2006 ) 113 Circulation : 2462 -2472.

    • Search Google Scholar
  • Chaitman BR, Pepine CJ, Parker JO, Skopal MJ, Chumakova G, Kuch J, Wang W, Skettino SL, Wolff Combination assessment of ranolazine in stable angina (CARISA) investigators: Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. JAMA 291, 309–316 (2004)

    Wolff A.A. , 'Combination assessment of ranolazine in stable angina (CARISA) investigators: Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial ' (2004 ) 291 JAMA : 309 -316.

    • Search Google Scholar
  • Chisholm JW, Goldfine AB, Dhalla AK, Braunwald E, Morrow DA, Karwatowska-Prokopczuk E, Belardinelli L: Effect of ranolazine on HbA1c and glucose levels in hyperglycemic patients with non-ST elevation acute coronary syndrome. Diabetes Care 33, 1163–1168 (2010)

    Belardinelli L. , 'Effect of ranolazine on HbA1c and glucose levels in hyperglycemic patients with non-ST elevation acute coronary syndrome ' (2010 ) 33 Diabetes Care : 1163 -1168.

    • Search Google Scholar
  • Deshmukh SH, Patel SR, Pinassi E, Mindrescu C, Hermance EV, Infantino MN, Coppola JT, Staniloae CS: Ranolazine improves endothelial function in patients with stable coronary artery disease. Coron. Artery Dis. 20, 343–347 (2009)

    Staniloae C.S. , 'Ranolazine improves endothelial function in patients with stable coronary artery disease ' (2009 ) 20 Coron. Artery Dis. : 343 -347.

    • Search Google Scholar
  • Dhalla AK, Wang WQ, Dow J, Shryock JC, Belardinelli L, Bhandari A, Kloner RA: Ranolazine, an antianginal agent, markedly reduces ventricular arrhythmias induced by ischemia and ischemia-reperfusion. Am. J. Physiol. Heart Circ. Physiol. 297, H1923–H1929 (2009)

    Kloner R.A. , 'Ranolazine, an antianginal agent, markedly reduces ventricular arrhythmias induced by ischemia and ischemia-reperfusion ' (2009 ) 297 Am. J. Physiol. Heart Circ. Physiol. : H1923 -H1929.

    • Search Google Scholar
  • Fraser H, Belardinelli L, Wang L, Light PE, McVeigh JJ, Clanachan AS: Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts. J. Mol. Cell. Cardiol. 41, 1031–1038 (2006)

    Clanachan A.S. , 'Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts ' (2006 ) 41 J. Mol. Cell. Cardiol. : 1031 -1038.

    • Search Google Scholar
  • Lee L, Horowitz J, Frenneaux M: Metabolic manipulation in ischaemic heart disease, a novel approach to treatment. Eur. Heart J. 25, 634–641 (2004)

    Frenneaux M. , 'Metabolic manipulation in ischaemic heart disease, a novel approach to treatment ' (2004 ) 25 Eur. Heart J. : 634 -641.

    • Search Google Scholar
  • MacInnes A, Fairman DA, Binding P, Rhodes J, Wyatt MJ, Phelan A, Haddock PS, Karran EH: The antianginal agent trimetazidine does not exert its functional benefit via inhibition of mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ. Res. 93, e26–e32 (2003)

    Karran E.H. , 'The antianginal agent trimetazidine does not exert its functional benefit via inhibition of mitochondrial long-chain 3-ketoacyl coenzyme A thiolase ' (2003 ) 93 Circ. Res. : e26 -e32.

    • Search Google Scholar
  • Mahmoudian M, Behnaz F, Rezaei E: Diabetes-induced changes in the contractility of the aorta and pA2 of nifedipine in the rat. Acta Diabetol. 33, 114–117 (1996)

    Rezaei E. , 'Diabetes-induced changes in the contractility of the aorta and pA2 of nifedipine in the rat ' (1996 ) 33 Acta Diabetol. : 114 -117.

    • Search Google Scholar
  • Maier LS: A novel mechanism for the treatment of angina, arrhythmias, and diastolic dysfunction: inhibition of late INa using ranolazine. J. Cardiovasc. Pharmacol. 54, 279–286 (2009)

    Maier L.S. , 'A novel mechanism for the treatment of angina, arrhythmias, and diastolic dysfunction: inhibition of late INa using ranolazine ' (2009 ) 54 J. Cardiovasc. Pharmacol. : 279 -286.

    • Search Google Scholar
  • Morrow DA, Scirica BM, Chaitman BR, McGuire DK, Murphy SA, Karwatowska-Prokopczuk E, McCabe CH, Braunwald E: MERLIN-TIMI 36 Investigators: Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trial. Circulation 119, 2032–2039 (2009)

    Braunwald E. , 'MERLIN-TIMI 36 Investigators: Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trial ' (2009 ) 119 Circulation : 2032 -2039.

    • Search Google Scholar
  • Newgreen DT, Bray KM, McHarg AD, Weston AH, Duty S, Brown BS, Kay PB, Edwards G, Longmore J, Southerton JS: The action of diazoxide and minoxidil sulphate on rat blood vessels: a comparison with cromakalim. Br. J. Pharmacol. 100, 605–613 (1990)

    Southerton J.S. , 'The action of diazoxide and minoxidil sulphate on rat blood vessels: a comparison with cromakalim ' (1990 ) 100 Br. J. Pharmacol. : 605 -613.

    • Search Google Scholar
  • Nieminen T, Tavares C, Pegler JR, Belardinelli L, Verrier RL: Ranolazine injection into coronary or femoral arteries exerts marked, transient regional vasodilation without systemic hypotension in an intact porcine model. Circ. Cardiovasc. Interv. 4, 481–487 (2011)

    Verrier R.L. , 'Ranolazine injection into coronary or femoral arteries exerts marked, transient regional vasodilation without systemic hypotension in an intact porcine model ' (2011 ) 4 Circ. Cardiovasc. Interv. : 481 -487.

    • Search Google Scholar
  • Sabbah HN, Chandler MP, Mishima T, Suzuki G, Chaudhry P, Nass O, Biesiadecki BJ, Blackburn B, Wolff A, Stanley WC: Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failure. J. Card. Fail. 8, 416–422 (2002)

    Stanley W.C. , 'Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failure ' (2002 ) 8 J. Card. Fail. : 416 -422.

    • Search Google Scholar
  • Saint DA: The cardiac persistent sodium current: an appealing therapeutic target? Br. J. Pharmacol. 153, 1133–1142 (2008)

    Saint D.A. , 'The cardiac persistent sodium current: an appealing therapeutic target? ' (2008 ) 153 Br. J. Pharmacol. : 1133 -1142.

    • Search Google Scholar
  • Scarborough NL, Carrier GO: Nifedipine and alpha adrenoceptors in rat aorta. II. Role of extracellular calcium in enhanced alpha-2 adrenoceptor-mediated contraction in diabetes. J. Pharmacol. Exp. Ther. 231, 603–609 (1984)

    Carrier G.O. , 'Nifedipine and alpha adrenoceptors in rat aorta. II. Role of extracellular calcium in enhanced alpha-2 adrenoceptor-mediated contraction in diabetes ' (1984 ) 231 J. Pharmacol. Exp. Ther. : 603 -609.

    • Search Google Scholar
  • Timmis AD, Chaitman BR, Crager M: Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes. Eur. Heart J. 27, 42–48 (2006)

    Crager M. , 'Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes ' (2006 ) 27 Eur. Heart J. : 42 -48.

    • Search Google Scholar
  • Wang WQ, Robertson Ch, Dhalla A K, Belardinelli L: Antitorsadogenic effects of (±)-N-(2,6-dimethyl-phenyl)-(4[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazine(Ranolazine) in anesthetized rabbits. J. Pharmacol. Exp. Ther. 325, 875–881 (2008)

    Belardinelli L. , 'Antitorsadogenic effects of (±)-N-(2,6-dimethyl-phenyl)-(4[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazine(Ranolazine) in anesthetized rabbits ' (2008 ) 325 J. Pharmacol. Exp. Ther. : 875 -881.

    • Search Google Scholar
  • Xue YL, Shi HX, Murad F, Bian K: Vasodilatory effects of cinnamaldehyde and its mechanism of action in the rat aorta. Vasc. Health Risk Manag. 7, 273–280 (2011)

    Bian K. , 'Vasodilatory effects of cinnamaldehyde and its mechanism of action in the rat aorta ' (2011 ) 7 Vasc. Health Risk Manag. : 273 -280.

    • Search Google Scholar
  • Zhao G, Walsh E, Shryock JC, Messina E, Wu Y, Zeng D, Xu X, Ochoa M, Baker SP, Hintze TH, Belardinelli L: Antiadrenergic and hemodynamic effects of ranolazine in conscious dogs. J. Cardiovasc. Pharmacol. 57, 639–647 (2011)

    Belardinelli L. , 'Antiadrenergic and hemodynamic effects of ranolazine in conscious dogs ' (2011 ) 57 J. Cardiovasc. Pharmacol. : 639 -647.

    • Search Google Scholar

The author instruction is available in PDF.

Please, download the file from HERE

Senior editors

Editor(s)-in-Chief: Rosivall, László

Honorary Editor(s)-in-Chief): Monos, Emil

Managing Editor(s): Bartha, Jenő; Berhidi, Anna

Co-editor(s): Koller, Ákos; Lénárd, László; Szénási, Gábor

Assistant Editor(s): G. Dörnyei (Budapest), Zs. Miklós (Budapest), Gy. Nádasy (Budapest)

Hungarian Editorial Board

      Benedek, György (Szeged)
      Benyó, Zoltán (Budapest)
      Boros, Mihály (Szeged)
      Chernoch, László (Debrecen)
      Détári, László (Budapest)
      Hamar, János (Budapest)
      Hantos, Zoltán (Szeged)
      Hunyady, László (Budapest)
      Imre, Sándor (Debrecen)
      Jancsó, Gábor (Szeged)
      Karádi, Zoltán (Pécs)
      Kovács, László (Debrecen)
      Palkovits, Miklós (Budapest)
      Papp, Gyula (Szeged)
      Pavlik, Gábor (Budapest)
      Spät, András (Budapest)
      Szabó, Gyula (Szeged)
      Szelényi, Zoltán (Pécs)
      Szolcsányi, János (Pécs)
      Szollár, Lajos (Budapest)
      Szücs, Géza (Debrecen)
      Telegdy, Gyula (Szeged)
      Toldi, József (Szeged)
      Tósaki, Árpád (Debrecen)

International Editorial Board

      R. Bauer (Jena)
      W. Benjelloun (Rabat)
      A. W. Cowley Jr. (Milwaukee)
      D. Djuric (Belgrade)
      C. Fry (London)
      S. Greenwald (London)
      O. Hänninen (Kuopio)
      H. G. Hinghofer-Szalkay (Graz)
      Th. Kenner (Graz)
      Gy. Kunos (Richmond)
      M. Mahmoudian (Tehran)
      T. Mano (Seki, Gifu)
      G. Navar (New Orleans)
      H. Nishino (Nagoya)
      O. Petersen (Liverpool)
      U. Pohl (Münich)
      R. S. Reneman (Maastricht)
      A. Romanovsky (Phoenix)
      G. M. Rubanyi (Richmond)
      T. Sakata (Oita)
      A. Siddiqui (Karachi)
      Cs. Szabo (Beverly)
      E. Vicaut (Paris)
      N. Westerhof (Amsterdam)
      L. F. Zhang (Xi'an)

Editorial Office:
Akadémiai Kiadó Zrt.
Prielle Kornélia u. 21–35, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Physiologica Hungarica
Semmelweis University, Faculty of Medicine Institute of Pathophysiology
Nagyvárad tér 4, H-1089 Budapest, Hungary
Phone/Fax: +36-1-2100-100
E-mail: aph@semmelweis-univ.hu

Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • EMBASE/Excerpta Medica
  • Global Health
  • Index Copernicus
  • Index Medicus
  • Medline
  • Referativnyi Zhurnal
  • Science Citation Index Expanded
  • SCOPUS

 

Acta Physiologica Hungarica
Language English
Size  
Year of
Foundation
1950
Publication
Programme
changed title
Volumes
per Year
 
Issues
per Year
 
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 0231-424X (Print)
ISSN 1588-2683 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Apr 2021 0 0 0
May 2021 0 0 0
Jun 2021 0 0 0
Jul 2021 0 0 0
Aug 2021 0 0 0
Sep 2021 2 0 0
Oct 2021 1 0 0